Geode Capital Management
MGRX icon

Geode Capital Management’s Mangoceuticals MGRX Stock Holding History

Geode Capital Management’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$295K Buy
689,270
+533,027
+341% +$236K ﹤0.01% 3743
2026
Q2 		$59.4K Sell
156,243
-38,239
-20% -$14.7K ﹤0.01% 4206
2026
Q1 		$70K Buy
194,482
+86,160
+80% +$41.3K ﹤0.01% 4233
2025
Q4 		$80.2K Buy
108,322
+20,348
+23% +$33K ﹤0.01% 4149
2025
Q3 		$193K Buy
87,974
+61,476
+232% +$115K ﹤0.01% 3934
2025
Q2 		$40.3K Buy
26,498
+6,928
+35% +$13K ﹤0.01% 4256
2025
Q1 		$38.2K Buy
19,570
+7,567
+63% +$27.2K ﹤0.01% 4238
2024
Q4 		$29.2K Buy
12,003
+3,248
+37% +$8.51K ﹤0.01% 4331
2024
Q3 		$31K Buy
+8,755
New +$41.3K ﹤0.01% 4351

Other funds holding MGRX

Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Ackerman Capital Advisors
Ackerman Capital Advisors Dallas, Texas $512M AUM 10.78% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
ACT Advisors
ACT Advisors Asheville, North Carolina $308M AUM 16.31% 1-Year Est. Return
Csenge Advisory Group
Csenge Advisory Group Clearwater, Florida $2.53B AUM 18.15% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Geode Capital Management's MGRX Position: Q3 2026 in Review

Geode Capital Management increased its Mangoceuticals (MGRX) stake by 341% in Q3 2026, buying an estimated $236K and bringing the position to 689,270 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

Geode Capital Management first reported a position in MGRX in Q3 2024 and has held it in 9 quarters since. 7 funds tracked by Wall St. Rank hold MGRX as of Q3 2026.

  • Geode Capital Management held 689,270 shares of Mangoceuticals worth $295K as of Q3 2026.
  • Geode Capital Management bought 533,027 Mangoceuticals shares in Q3 2026, an estimated $236K.
  • Mangoceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3743 holding.
  • Geode Capital Management first reported a position in Mangoceuticals in Q3 2024 and has held it in 9 quarters since.
  • 7 funds tracked by Wall St. Rank held Mangoceuticals as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.